Global /India /Healthcare /Drug Manufacturers - General /WANBURY

Wanbury Ltd.

WANBURY

• NSE: WANBURY • Delayed

254.28INR -1.4%

2.67 USD

As of 6 June 2026, Wanbury Ltd. has a market cap of $94.2M USD, ranking #25980 globally and #1573 in India. It ranks #2335 in the Healthcare sector, and #841 in the Drug Manufacturers - General industry.

Global Rank

25980

Country Rank

1573

Sector Rank

2335

Industry Rank

841

Key Stats

Market Cap

$94.2MUSD

9.02B INR

Enterprise Value

$114.02MUSD

10.88B INR

Revenue (TTM)

$68.76MUSD

6.58B INR

EBITDA (TTM)

$11.07MUSD

1.06B INR

Net Income (TTM)

$6.76MUSD

646.86M INR

EBITDA Margin

16%

Profit Margin

9.8%

PE Ratio

13.9

PS Ratio

1.4

PB Ratio

8.4

EV/EBITDA

10.0

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mohan Rayana open_in_new

Employees

1,382

Founded

1988

Website

wanbury.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.4%	-0.1%	14%	37%	0.7%	14%	2.4%	422%	136%

Upcoming Earnings

Earnings Date

Thu, Jun 11

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	WANBURY Wanbury Ltd ISIN: INE107F01022 Shares Out.: Shares Outstanding: 34.939M¹ Shares Float: 17.296M² TV: TradingView: NSE: WANBURY SA: Stock Analysis: NSE: WANBURY YF: Yahoo Finance: WANBURY.NS GF: Google Finance: NSE: WANBURY BA: Barron's: WANBURY MS: Morningstar: XNSE: WANBURY	254.28 INR	TV: TradingView: NSE: WANBURY SA: Stock Analysis: NSE: WANBURY YF: Yahoo Finance: WANBURY.NS GF: Google Finance: NSE: WANBURY BA: Barron's: WANBURY MS: Morningstar: XNSE: WANBURY
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	524212 (WANBURY) Wanbury Ltd ISIN: INE107F01022 TV: TradingView: BSE: WANBURY SA: Stock Analysis: BOM: 524212 YF: Yahoo Finance: 524212.BO GF: Google Finance: BOM: 524212 BA: Barron's: 524212 MS: Morningstar: XBOM: 524212	258.50 INR	TV: TradingView: BSE: WANBURY SA: Stock Analysis: BOM: 524212 YF: Yahoo Finance: 524212.BO GF: Google Finance: BOM: 524212 BA: Barron's: 524212 MS: Morningstar: XBOM: 524212

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Wanbury Ltd.

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.57B 4.27T INR 47K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.12B 1.73T INR 19K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$14.95B 1.43T INR 16K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.57B 1.11T INR 12K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.73B 931.67B INR 10K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.57B 916.53B INR 10K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 808K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 581K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 383K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 345K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 307K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 294K%	20.5	Switzerland

chevron_leftBack